Cargando…

Are mitophagy enhancers therapeutic targets for Alzheimer’s disease?

Healthy mitochondria are essential for functional bioenergetics, calcium signaling, and balanced redox homeostasis. Dysfunctional mitochondria are a central aspect of aging and neurodegenerative diseases such as Alzheimer’s disease (AD). The formation and accumulation of amyloid beta (Aβ) and hyperp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pradeepkiran, Jangampalli Adi, Hindle, Ashly, Kshirsagar, Sudhir, Reddy, P. Hemachandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148418/ https://www.ncbi.nlm.nih.gov/pubmed/35585708 http://dx.doi.org/10.1016/j.biopha.2022.112918

Ejemplares similares

Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease?
por: Hindle, Ashly, et al.
Publicado: (2022)

Early Cellular, Molecular, Morphological and Behavioral Changes in the Humanized Amyloid-Beta-Knock-In Mouse Model of Late-Onset Alzheimer’s Disease
por: Kshirsagar, Sudhir, et al.
Publicado: (2022)

A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer’s Disease
por: Kshirsagar, Sudhir, et al.
Publicado: (2022)

Rlip Reduction Induces Oxidative Stress and Mitochondrial Dysfunction in Mutant Tau-Expressed Immortalized Hippocampal Neurons: Mechanistic Insights
por: Reddy, P. Hemachandra, et al.
Publicado: (2023)

Structure Based Design and Molecular Docking Studies for Phosphorylated Tau Inhibitors in Alzheimer’s Disease
por: Pradeepkiran, Jangampalli Adi, et al.
Publicado: (2019)

A partial reduction of VDAC1 enhances mitophagy, autophagy, synaptic activities in a transgenic Tau mouse model
por: Vijayan, Murali, et al.
Publicado: (2022)

MicroRNA-455-3p improves synaptic, cognitive functions and extends lifespan: Relevance to Alzheimer's disease
por: Kumar, Subodh, et al.
Publicado: (2021)

Defective Autophagy and Mitophagy in Aging and Alzheimer’s Disease
por: Tran, Michael, et al.
Publicado: (2021)

Insights of rheumatoid arthritis risk factors and associations
por: Pradeepkiran, Jangampalli Adi
Publicado: (2019)

RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
por: Awasthi, Sanjay, et al.
Publicado: (2021)

Aquaculture role in global food security with nutritional value: a review
por: Pradeepkiran, Jangampalli Adi
Publicado: (2019)

Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
por: Reddy, P. Hemachandra, et al.
Publicado: (2019)

Expression and Function of StAR in Cancerous and Non-Cancerous Human and Mouse Breast Tissues: New Insights into Diagnosis and Treatment of Hormone-Sensitive Breast Cancer
por: Manna, Pulak R., et al.
Publicado: (2023)

Discovery of small molecules through pharmacophore modeling, docking and molecular dynamics simulation against Plasmodium vivax Vivapain-3 (VP-3)
por: Saddala, Madhu Sudhana, et al.
Publicado: (2018)

Mitochondrial Oxidative Damage in Aging and Alzheimer's Disease: Implications for Mitochondrially Targeted Antioxidant Therapeutics
por: Reddy, P. Hemachandra
Publicado: (2006)

Modeling, molecular docking, probing catalytic binding mode of acetyl-CoA malate synthase G in Brucella melitensis 16M
por: Adi, Pradeepkiran Jangampalli, et al.
Publicado: (2016)

Modeling, molecular dynamics, and docking assessment of transcription factor rho: a potential drug target in Brucella melitensis 16M
por: Pradeepkiran, Jangampalli Adi, et al.
Publicado: (2015)

Complete genome-wide screening and subtractive genomic approach revealed new virulence factors, potential drug targets against bio-war pathogen Brucella melitensis 16M
por: Pradeepkiran, Jangampalli Adi, et al.
Publicado: (2015)

Pharmacological Potentiality of Bioactive Flavonoid against Ketamine Induced Cell Death of PC 12 Cell Lines: An In Vitro Study
por: Venkataramaiah, Chintha, et al.
Publicado: (2021)

Conformational transition pathway of R308K mutant glucokinase in the presence of the glucokinase activator YNKGKA4
por: Yellapu, Nanda Kumar, et al.
Publicado: (2018)

Calcium, zinc and vitamin E ameliorate cadmium-induced renal oxidative damage in albino Wistar rats
por: Adi, Pradeepkiran Jangampalli, et al.
Publicado: (2016)

Therapeutics of Alzheimer’s Disease: Recent Developments
por: Burns, Scott, et al.
Publicado: (2022)

Rlip Depletion Alters Oncogene Transcription at Multiple Distinct Regulatory Levels
por: Hindle, Ashly, et al.
Publicado: (2022)

Three Novel Mutations I65S, R66S, and G86R Divulge Significant Conformational Variations in the PTB Domain of the IRS1 Gene
por: Veeraragavulu, Praveen Chakravarthi, et al.
Publicado: (2019)

Mitophagy in Alzheimer’s disease: Molecular defects and therapeutic approaches
por: Mary, Arnaud, et al.
Publicado: (2022)

Sunflower-Assisted Bio-Derived ZnO-NPs as an Efficient Nanocatalyst for the Synthesis of Novel Quinazolines with Highly Antioxidant Activities
por: S., Mahesh, et al.
Publicado: (2022)

Novel 1, 4-dihydropyridines for L-type calcium channel as antagonists for cadmium toxicity
por: Saddala, Madhu Sudhana, et al.
Publicado: (2017)

The Contribution of Hippocampal All-Trans Retinoic Acid (ATRA) Deficiency to Alzheimer’s Disease: A Narrative Overview of ATRA-Dependent Gene Expression in Post-Mortem Hippocampal Tissue
por: Almaguer, Joey, et al.
Publicado: (2023)

Therapeutic targeting of mitophagy in Parkinson's disease
por: Masaldan, Shashank, et al.
Publicado: (2022)

Targeting MCL1 to induce mitophagy is a potential therapeutic strategy for Alzheimer disease
por: Cen, Xufeng, et al.
Publicado: (2020)

CGMD: An integrated database of cancer genes and markers
por: Pradeepkiran, Jangampalli Adi, et al.
Publicado: (2015)

Reduced VDAC1, Maintained Mitochondrial Dynamics and Enhanced Mitochondrial Biogenesis in a Transgenic Tau Mouse Model of Alzheimer’s Disease
por: Vijayan, Murali, et al.
Publicado: (2022)

Mitochondrial Dysfunction and Oxidative Stress in Asthma: Implications for Mitochondria-Targeted Antioxidant Therapeutics
por: Reddy, P. Hemachandra
Publicado: (2011)

Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias in African Americans: Focus on Caregivers
por: Kopel, Jonathan, et al.
Publicado: (2023)

Dynamics of Dynamin-Related Protein 1 in Alzheimer’s Disease and Other Neurodegenerative Diseases
por: Oliver, Darryll, et al.
Publicado: (2019)

Therapeutic Effects of BT2 in the Hippocampus of Alzheimer's Disease Mouse Model
por: Mullins, Caitlyn, et al.
Publicado: (2022)

Age-Related Chronic Diseases and Alzheimer’s Disease in Texas: A Hispanic Focused Study
por: Sheladia, Shyam, et al.
Publicado: (2021)

Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease
por: Calkins, Marcus J., et al.
Publicado: (2012)

Amyloid Beta in Aging and Alzheimer’s Disease
por: Sehar, Ujala, et al.
Publicado: (2022)

Defective mitophagy and the etiopathogenesis of Alzheimer’s disease
por: Zeng, Kuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sk7s56737f7uhnhokq91k26u8g